Chemical exchange saturation transfer (CEST) MRI at 3 T suffers from low specificity due to overlapping CEST effects from multiple metabolites, while higher field strengths (B0) allow for better separation of Z-spectral "peaks," aiding signal interpretation and quantification. However, data acquisition at higher B0 is restricted by equipment access, field inhomogeneity and safety issues. Herein, we aim to synthesize higher-B0 Z-spectra from readily available data acquired with 3 T clinical scanners using a deep learning framework. Trained with simulation data using models based on Bloch-McConnell equations, this framework comprised two deep neural networks (DNNs) and a singular value decomposition (SVD) module. The first DNN identified B0 shifts in Z-spectra and aligned them to correct frequencies. After B0 correction, the lower-B0 Z-spectra were streamlined to the second DNN, casting into the key feature representations of higher-B0 Z-spectra, obtained through SVD truncation. Finally, the complete higher-B0 Z-spectra were recovered from inverse SVD, given the low-rank property of Z-spectra. This study constructed and validated two models, a phosphocreatine (PCr) model and a pseudo-in-vivo one. Each experimental dataset, including PCr phantoms, egg white phantoms, and in vivo rat brains, was sequentially acquired on a 3 T human and a 9.4 T animal scanner. Results demonstrated that the synthetic 9.4 T Z-spectra were almost identical to the experimental ground truth, showing low RMSE (0.11% ± 0.0013% for seven PCr tubes, 1.8% ± 0.2% for three egg white tubes, and 0.79% ± 0.54% for three rat slices) and high R2 (>0.99). The synthesized amide and NOE contrast maps, calculated using the Lorentzian difference, were also well matched with the experiments. Additionally, the synthesis model exhibited robustness to B0 inhomogeneities, noise, and other acquisition imperfections. In conclusion, the proposed framework enables synthesis of higher-B0 Z-spectra from lower-B0 ones, which may facilitate CEST MRI quantification and applications.